Acute myocardial infarction followed by technetium-99m-sestamibi SPECT imaging and pathologic correlation

Journal of Nuclear Medicine

Volumn 38, Issue 12, 1997, Pages 1837-1840

  Hurrell, David G ^b   Edwards, William D ^b   O'Connor, Michael K ^b   Gibbons, Raymond J ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Myocardial infarction; SPECT; Technetium 99m sestamibi; Thrombolytic therapy

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLOOD CLOT LYSIS; CADAVER; CASE REPORT; CORONARY RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART INFARCTION SIZE; HEART SCINTISCANNING; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; HEART; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PLASMINOGEN ACTIVATORS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TECHNETIUM TC 99M SESTAMIBI; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031472585     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328:685-691.
2. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile. J Am Coll Cardiol 1988;12:1573-1581.
3. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m-methoxyisobutyl-isonitrile. Circulation 1990;82:1424-1437.
4. Medrano R, Weilbaacher D, Young JB, et al. Assessment of myocardial viability with technetium-99m sestamibi in patients undergoing cardiac transplantation: a scintigraphic-pathologic study [Abstract]. Circulation 1992;86(suppl I):I-108.
5. 99mTc-hexakis-2 methoxy-2 methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989;80:1277-1286.
6. O'Connor MK, Hammell TC, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percent myocardium at risk following administration of Tc99m isonitrile. Eur J Nucl Med 1990;17:69-76.
7. Maron BJ, Henry WL, Roberts WC, et al. Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation 1977;55:341-346.
8. Edwards WD. Pathology of myocardial infarction and reperfusion. In: Gersh BJ, Rahimtoola SH, eds. Acute myocardial infarction. New York: Elsevior; 1991:14-48.
9. Lowe JE, Reimer KA, Jennings RB. Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol 1978;90:373-376.
10. Reimer KA, Jennings RB, Cobb RF, et al. Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models. Circ Res 1985;56:651-665.
11. 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-341.
12. Feiring AJ, Johnson MR, Kioschos JM, Kirchner PT, Marcus ML, White CW. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation 1987;75:980-987.
13. Gibbons RJ, Christian TF, Hopfenspirger M, Hodge DO, Bailey KR. Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention. J Am Coll Cardiol 1994;24:616-623.